Abbott Laboratories’ Associated Business Segments

Abbott is organized around a broad portfolio—established pharmaceutical products, diagnostic products, nutritional products, and vascular products.

Mike Benson - Author

Aug. 4 2015, Published 12:01 p.m. ET


Business segments

Abbott Laboratories is a US pharmaceutical and healthcare company with a significant presence worldwide. Abbott is organized around a broad and diversified portfolio of healthcare products classified under four business segments:

  • established pharmaceutical products
  • diagnostic products
  • nutritional products
  • vascular products
Article continues below advertisement
Article continues below advertisement

The nutritional products segment contributes over 34% of the total revenue for Abbott Laboratories (ABT). Diagnostics products, established pharmaceuticals, and vascular franchise contribute ~23.30%, ~15.40%, and ~14.70%, respectively.

Established pharmaceutical products

The established pharmaceutical products segment deals with a broad line of branded generic pharmaceuticals that are manufactured worldwide. These products are marketed and sold outside the US. The EPD (Established Pharmaceuticals Division) doesn’t distribute or sell its products in the US. The key products and therapeutic areas under EPD are:

  • gastroenterology products including Creon, Duspatal, Dicetel, Heptral, Transmetil, Samyr, Donamet, and Duphalac
  • women’s health products including Duphaston and Femoston
  • cardiovascular and metabolic products including Lipanthyl, TriCor, Teventen, Physiotens, and Synthroid
  • pain and central nervous system products including Serc and Brufen
  • respiratory drugs and vaccines including Biaxin, Klacid, Klaricid, and Influvac
Article continues below advertisement

Diagnostic products

This segment includes a broad line of diagnostic systems and tests manufactured and marketed worldwide to blood banks, hospitals, commercial laboratories, physicians, government agencies, and plasma protein therapeutic companies. The key products include:

  • immunoassay and clinical chemistry systems
  • assays used for screening and diagnosis for abused drugs, cancer, therapeutic drug monitoring, fertility, physiological diseases, and infectious diseases
  • hematology systems
  • informatics and automation solutions for use in laboratories

Nutritional products

This segment includes a broad line of pediatric and adult nutritional products manufactured and marketed worldwide. The key products in this segment include:

  • infant formula and follow-on formula under Similac brand
  • adult and other pediatric nutritional products under Ensure, PediaSure, and Glucerna brands
  • nutritional products for use in enteral feeding in healthcare institutions

Vascular products

This segment includes a broad line of coronary, endovascular, vessel closure, and structural heart devices for the treatment of vascular diseases. These products are manufactured and marketed worldwide. The key products in this segment are:

  • Xience brand coronary stent systems developed on Multi-Link Vision platform
  • drug-eluting coronary bioresorbable vascular scaffold—Absorb.
  • coronary metallic stents
  • coronary balloon dilatation products
  • vessel closure devices
  • carotid and vascular stent systems

The Health Care Select Sector SPDR ETF (XLV) has invested ~2.30% in Abbott (ABT), ~2.90% in Eli Lilly and Co. (LLY), ~9.50% in Johnson & Johnson (JNJ), and ~7.30% in Pfizer (PFE). Investors can choose other ETFs like the iShares US healthcare ETF (IYH) for diversification in pharmaceuticals and healthcare companies.


Latest Health Care Select Sector SPDR® ETF News and Updates

    Opt-out of personalized ads

    © Copyright 2024 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.